Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Citrullination | 3 | 2025 | 36 | 1.070 |
Why?
|
| Benzimidazoles | 3 | 2023 | 54 | 0.850 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2023 | 12 | 0.820 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2023 | 337 | 0.780 |
Why?
|
| Antineoplastic Agents | 2 | 2024 | 662 | 0.580 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2023 | 505 | 0.560 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 791 | 0.410 |
Why?
|
| Apoptosis | 2 | 2024 | 1080 | 0.260 |
Why?
|
| Protein-Arginine Deiminases | 2 | 2023 | 86 | 0.250 |
Why?
|
| Bone Morphogenetic Proteins | 2 | 2023 | 62 | 0.250 |
Why?
|
| NF-kappa B | 2 | 2025 | 469 | 0.250 |
Why?
|
| Nucleotidyltransferases | 2 | 2023 | 62 | 0.240 |
Why?
|
| Acetamides | 1 | 2025 | 13 | 0.240 |
Why?
|
| Transcription Factor RelA | 1 | 2025 | 50 | 0.220 |
Why?
|
| Acute Lung Injury | 1 | 2025 | 45 | 0.220 |
Why?
|
| Siderophores | 1 | 2024 | 11 | 0.220 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2024 | 83 | 0.210 |
Why?
|
| High-Throughput Screening Assays | 1 | 2024 | 78 | 0.210 |
Why?
|
| Anthelmintics | 1 | 2024 | 47 | 0.210 |
Why?
|
| Premature Birth | 1 | 2025 | 112 | 0.210 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2024 | 98 | 0.210 |
Why?
|
| Cyclic GMP | 1 | 2023 | 31 | 0.200 |
Why?
|
| Herpes Simplex | 1 | 2023 | 50 | 0.200 |
Why?
|
| Citrulline | 1 | 2023 | 44 | 0.200 |
Why?
|
| Herpesvirus 1, Human | 1 | 2023 | 82 | 0.200 |
Why?
|
| Structure-Activity Relationship | 2 | 2024 | 373 | 0.200 |
Why?
|
| NAD | 1 | 2023 | 53 | 0.200 |
Why?
|
| Axons | 1 | 2023 | 123 | 0.190 |
Why?
|
| Osteogenesis | 1 | 2023 | 143 | 0.190 |
Why?
|
| Proteome | 1 | 2023 | 150 | 0.190 |
Why?
|
| Smad Proteins | 1 | 2022 | 22 | 0.190 |
Why?
|
| Macrophages | 2 | 2025 | 1041 | 0.190 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2024 | 866 | 0.190 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2023 | 140 | 0.190 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2023 | 264 | 0.180 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2023 | 158 | 0.180 |
Why?
|
| Interferon Type I | 1 | 2023 | 187 | 0.180 |
Why?
|
| Proteins | 2 | 2023 | 753 | 0.170 |
Why?
|
| Sepsis | 1 | 2024 | 289 | 0.170 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 385 | 0.160 |
Why?
|
| Topoisomerase Inhibitors | 1 | 2020 | 4 | 0.160 |
Why?
|
| DNA Topoisomerases | 1 | 2020 | 4 | 0.160 |
Why?
|
| Staphylococcus epidermidis | 1 | 2020 | 10 | 0.160 |
Why?
|
| Cell Proliferation | 1 | 2024 | 988 | 0.160 |
Why?
|
| Hep G2 Cells | 1 | 2020 | 28 | 0.160 |
Why?
|
| A549 Cells | 1 | 2020 | 39 | 0.160 |
Why?
|
| Indoles | 1 | 2020 | 110 | 0.150 |
Why?
|
| Quinazolines | 1 | 2019 | 22 | 0.150 |
Why?
|
| Humans | 11 | 2025 | 63533 | 0.150 |
Why?
|
| Quantum Dots | 1 | 2019 | 30 | 0.150 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2020 | 205 | 0.150 |
Why?
|
| Amino Acids | 1 | 2020 | 147 | 0.150 |
Why?
|
| Inflammation | 1 | 2025 | 1146 | 0.150 |
Why?
|
| Staphylococcus aureus | 1 | 2020 | 176 | 0.150 |
Why?
|
| Fatty Acids | 1 | 2020 | 200 | 0.150 |
Why?
|
| HeLa Cells | 1 | 2020 | 536 | 0.140 |
Why?
|
| Signal Transduction | 2 | 2025 | 3033 | 0.140 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 188 | 0.140 |
Why?
|
| Membrane Proteins | 1 | 2023 | 899 | 0.130 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2019 | 172 | 0.130 |
Why?
|
| Escherichia coli | 1 | 2020 | 707 | 0.110 |
Why?
|
| Pseudomonas Infections | 2 | 2025 | 54 | 0.110 |
Why?
|
| Animals | 7 | 2025 | 20715 | 0.110 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2025 | 108 | 0.110 |
Why?
|
| Mice | 5 | 2025 | 10863 | 0.100 |
Why?
|
| Drug Discovery | 2 | 2024 | 95 | 0.100 |
Why?
|
| Bone Morphogenetic Protein Receptors | 2 | 2023 | 14 | 0.100 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 685 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 2 | 2025 | 3401 | 0.070 |
Why?
|
| RAW 264.7 Cells | 1 | 2025 | 54 | 0.060 |
Why?
|
| Placenta | 1 | 2025 | 61 | 0.060 |
Why?
|
| Trichuris | 1 | 2024 | 10 | 0.060 |
Why?
|
| Nematode Infections | 1 | 2024 | 11 | 0.060 |
Why?
|
| Intestinal Diseases, Parasitic | 1 | 2024 | 12 | 0.060 |
Why?
|
| Ancylostoma | 1 | 2024 | 26 | 0.060 |
Why?
|
| Nematoda | 1 | 2024 | 33 | 0.050 |
Why?
|
| Small Molecule Libraries | 1 | 2024 | 58 | 0.050 |
Why?
|
| Extracellular Traps | 1 | 2024 | 43 | 0.050 |
Why?
|
| Immunoglobulin M | 1 | 2023 | 115 | 0.050 |
Why?
|
| Molecular Structure | 1 | 2024 | 385 | 0.050 |
Why?
|
| Immunoglobulin A | 1 | 2023 | 96 | 0.050 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2022 | 8 | 0.050 |
Why?
|
| Biological Products | 1 | 2024 | 96 | 0.050 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2022 | 16 | 0.050 |
Why?
|
| Catalytic Domain | 1 | 2023 | 198 | 0.050 |
Why?
|
| Lipopolysaccharides | 1 | 2025 | 623 | 0.050 |
Why?
|
| Wound Healing | 1 | 2023 | 186 | 0.050 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2022 | 48 | 0.050 |
Why?
|
| Virus Replication | 1 | 2023 | 321 | 0.050 |
Why?
|
| HEK293 Cells | 1 | 2024 | 622 | 0.050 |
Why?
|
| Viral Proteins | 1 | 2023 | 263 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 171 | 0.050 |
Why?
|
| Cytokines | 1 | 2025 | 934 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2023 | 322 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2024 | 1470 | 0.040 |
Why?
|
| Esterases | 1 | 2019 | 13 | 0.040 |
Why?
|
| Drug Liberation | 1 | 2019 | 21 | 0.040 |
Why?
|
| DNA | 1 | 2023 | 838 | 0.040 |
Why?
|
| Lysosomes | 1 | 2019 | 166 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2023 | 1356 | 0.040 |
Why?
|
| Pregnancy | 1 | 2025 | 2335 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2025 | 2196 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2022 | 707 | 0.030 |
Why?
|
| Cell Survival | 1 | 2019 | 576 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2023 | 677 | 0.030 |
Why?
|
| Cell Line | 1 | 2019 | 2041 | 0.030 |
Why?
|
| Male | 2 | 2025 | 29937 | 0.030 |
Why?
|
| Female | 1 | 2025 | 32945 | 0.010 |
Why?
|